Q BioMed Inc (QBIO)

[dmort545]

Article that includes QBIO analysis. Looks good as a solid buy IMO.

http://www.themoneystreet.com/is-this-biotech-play-the-next-big-thing/?utm_source=qbio_yahoo_gemini&utm_medium=cpc_content.ad&utm_campaign=qbio-core.on.tms_new&utm_term=clear-vision&utm_content=core-content

The QBIO assets look solid:

Man 01 Glaucoma Drug is the first new drug in this area in 20 years. This “First in Class Drug” treats Intraocular Eye Pressure (IOP) with early tests indicating excellent results in normalizing IOP. This drug may be effective in helping ease the symptoms associated with:

Pediatric Glaucoma
Age Related Macular Degeneration (AMD)
Cystic Kidney Disease

CATALYST – Cancer Palliation Drug (FDA Approved) for metastatic bone cancer pain, is ready for manufacture and sales. The addition of this revenue asset sets this pipeline apart from the majority of small-cap biotech. This asset alone de-risks the investment in Q BioMed and provides a solid base to grow from.